UniQure slides on stock offering plans

uniQure

07/01/2025 22:16

**  U.S.-listed shares of UniQure NV  QURE.O  down 4% at
$16.93 after hours as gene therapy developer looks to raise
equity
  
    ** Netherlands-based firm  proposed offering of shares and
pre-funded warrants; deal size not disclosed
  
    ** QURE shares on Tues closed down 2.4% at $17.64
  
    ** With ~49 mln shares outstanding as of Jan 6, per the , co
has market value of roughly $865 mln
  
    ** Leerink acting as bookrunner for offering
  
    ** On Dec 10, QURE shares  ~110% to close at $15.30 after
after co  with the U.S. FDA for an accelerated approval path for
its Huntingdon's disease therapy, AMT-130
  
     

(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))